These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25195010)

  • 41. Discovery of 3(S)-thiomethyl pyrrolidine ERK inhibitors for oncology.
    Boga SB; Alhassan AB; Cooper AB; Doll R; Shih NY; Shipps G; Deng Y; Zhu H; Nan Y; Sun R; Zhu L; Desai J; Patel M; Muppalla K; Gao X; Wang J; Yao X; Kelly J; Gudipati S; Paliwal S; Tsui HC; Wang T; Sherborne B; Xiao L; Hruza A; Buevich A; Zhang LK; Hesk D; Samatar AA; Carr D; Long B; Black S; Dayananth P; Windsor W; Kirschmeier P; Bishop R
    Bioorg Med Chem Lett; 2018 Jun; 28(11):2029-2034. PubMed ID: 29748051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Breast cancer-derived factors stimulate osteoclastogenesis through the Ca2+/protein kinase C and transforming growth factor-beta/MAPK signaling pathways.
    Tiedemann K; Hussein O; Sadvakassova G; Guo Y; Siegel PM; Komarova SV
    J Biol Chem; 2009 Nov; 284(48):33662-70. PubMed ID: 19801662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Plasmin induces Cyr61 gene expression in fibroblasts via protease-activated receptor-1 and p44/42 mitogen-activated protein kinase-dependent signaling pathway.
    Pendurthi UR; Ngyuen M; Andrade-Gordon P; Petersen LC; Rao LV
    Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1421-6. PubMed ID: 12231560
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Two targets are better than one. Promising combination therapy to treat breast cancer.
    Franklin RA; Libra M; Stivala F; McCubrey JA
    Cancer Biol Ther; 2005 Nov; 4(11):1190-1. PubMed ID: 16322681
    [No Abstract]   [Full Text] [Related]  

  • 45. Signaling pathways leading to the induction of ornithine decarboxylase: opposite effects of p44/42 mitogen-activated protein kinase (MAPK) and p38 MAPK inhibitors.
    Flamigni F; Facchini A; Giordano E; Tantini B; Stefanelli C
    Biochem Pharmacol; 2001 Jan; 61(1):25-32. PubMed ID: 11137705
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of the MAPK/ERK pathway in valvular interstitial cell calcification.
    Gu X; Masters KS
    Am J Physiol Heart Circ Physiol; 2009 Jun; 296(6):H1748-57. PubMed ID: 19363136
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ERK mutations confer resistance to mitogen-activated protein kinase pathway inhibitors.
    Goetz EM; Ghandi M; Treacy DJ; Wagle N; Garraway LA
    Cancer Res; 2014 Dec; 74(23):7079-89. PubMed ID: 25320010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gallic acid induces the apoptosis of human osteosarcoma cells in vitro and in vivo via the regulation of mitogen-activated protein kinase pathways.
    Liang CZ; Zhang X; Li H; Tao YQ; Tao LJ; Yang ZR; Zhou XP; Shi ZL; Tao HM
    Cancer Biother Radiopharm; 2012 Dec; 27(10):701-10. PubMed ID: 22849560
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Suppression of lipopolysaccharide-induced cytokine production of gingival fibroblasts by a soybean, Kunitz trypsin inhibitor.
    Kobayashi H; Yoshida R; Kanada Y; Fukuda Y; Yagyu T; Inagaki K; Kondo T; Kurita N; Suzuki M; Kanayama N; Terao T
    J Periodontal Res; 2005 Dec; 40(6):461-8. PubMed ID: 16302924
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Divergent regulation by p44/p42 MAP kinase and p38 MAP kinase of bone morphogenetic protein-4-stimulated osteocalcin synthesis in osteoblasts.
    Kozawa O; Hatakeyama D; Uematsu T
    J Cell Biochem; 2002; 84(3):583-9. PubMed ID: 11813263
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Discovery of potent, orally bioavailable ERK1/2 inhibitors with isoindolin-1-one structure by structure-based drug design.
    Ji D; Zhang L; Zhu Q; Bai Y; Wu Y; Xu Y
    Eur J Med Chem; 2019 Feb; 164():334-341. PubMed ID: 30605831
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Signal transduction events involved in TPA downregulation of SP-A gene expression.
    Miakotina OL; Snyder JM
    Am J Physiol Lung Cell Mol Physiol; 2004 Jun; 286(6):L1210-9. PubMed ID: 14751851
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The ERK1/2 signaling pathway regulates 11beta-hydroxysteroid dehydrogenase type 2 expression in human trophoblast cells through a transcriptional mechanism.
    Guan H; Sun K; Yang K
    Biol Reprod; 2013 Oct; 89(4):92. PubMed ID: 23966319
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oral malodorous compound inhibits osteoblast proliferation.
    Imai T; Ii H; Yaegaki K; Murata T; Sato T; Kamoda T
    J Periodontol; 2009 Dec; 80(12):2028-34. PubMed ID: 19961386
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Apoptosis of liver cancer cells by vitamin K2 and enhancement by MEK inhibition.
    Matsumoto K; Okano J; Nagahara T; Murawaki Y
    Int J Oncol; 2006 Dec; 29(6):1501-8. PubMed ID: 17088989
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Low frequency pulsed electromagnetic field promotes C2C12 myoblasts proliferation via activation of MAPK/ERK pathway.
    Xu H; Zhang J; Lei Y; Han Z; Rong D; Yu Q; Zhao M; Tian J
    Biochem Biophys Res Commun; 2016 Oct; 479(1):97-102. PubMed ID: 27629357
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Sulindac sulfide inhibits epidermal growth factor-induced phosphorylation of extracellular-regulated kinase 1/2 and Bad in human colon cancer cells.
    Rice PL; Washington M; Schleman S; Beard KS; Driggers LJ; Ahnen DJ
    Cancer Res; 2003 Feb; 63(3):616-20. PubMed ID: 12566304
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of the transient pharmacological inhibition of Mapk3/1 pathway on ovulation in mice.
    Siddappa D; Beaulieu É; Gévry N; Roux PP; Bordignon V; Duggavathi R
    PLoS One; 2015; 10(3):e0119387. PubMed ID: 25803847
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Discovery of a Novel Inhibitor of the Protein Tyrosine Phosphatase Shp2.
    Chen C; Cao M; Zhu S; Wang C; Liang F; Yan L; Luo D
    Sci Rep; 2015 Dec; 5():17626. PubMed ID: 26626996
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Identification of the Raf-1 signaling pathway used by cAMP to inhibit p42/p44 MAPK in rat lacrimal gland acini: role in potentiation of protein secretion.
    Funaki C; Hodges RR; Dartt DA
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6321-8. PubMed ID: 20671279
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.